Respiratory Devices

Clinical trials for respiratory devices—including ventilators, CPAP/BiPAP machines, nebulizers, oxygen concentrators, and spirometers—require specialized protocols due to their direct impact on pulmonary function and life-sustaining care. Each phase demands rigorous attention to physiological endpoints, real-world usability, and acute safety risks.

Preclinical & Feasibility Studies

Bench testing for airflow accuracy, pressure stability, and fail-safe mechanisms (e.g., alarm triggers during hypoventilation).
Human factors studies to assess interface comfort (masks, nasal prongs) and clinician usability in emergency scenarios.
Key consideration: Simulate extreme conditions (e.g., high humidity, power outages) for ICU-grade devices.

Pilot Studies (First-in-Human)

Small cohorts (20–50 subjects) evaluate short-term safety in controlled settings (e.g., sleep labs for CPAP trials).
Primary metrics: Oxygen saturation (SpO₂), CO₂ retention, and patient-reported tolerance (e.g., mask leaks).
Critical risk: Monitor for barotrauma in ventilator trials or skin breakdown in long-term wearable devices.

Pivotal Trials (Regulatory Submissions)

Larger populations (100–500+ patients) stratified by disease severity (e.g., COPD GOLD stages for oxygen therapy).
Endpoints: Reduction in exacerbation rates (for chronic devices) or time-to-extubation (for acute ventilators).
Blinding challenges: Use sham devices for placebo-controlled trials (e.g., low-flow oxygen vs. room air).

Post-Market Surveillance (PMS)

Real-world evidence (RWE) collection via connected devices (e.g., remote monitoring of adherence in home CPAP users).
Long-term safety: Track rare events like pneumothorax or device-induced infections (e.g., ventilator-associated pneumonia).

End-to-End Clinical Trial Services

Protocol Design

Disease-specific frameworks: Tailored protocols for asthma (FEV₁ improvement), sleep apnea (AHI reduction), or ARDS (lung compliance).
Adaptive designs: Adjust enrollment criteria based on interim analyses (e.g., expanding to pediatric cohorts).

Ethics & Regulatory Strategy

Pre-submission meetings with FDA/CDRH or EMA/NB to align on ISO 80601-2-12 (ventilators) or ISO 17510 (sleep apnea devices).
Ethics committee training to address unique consent challenges (e.g., intubated patients in ICU trials).

Trial Site Selection

Tier-1 pulmonary centers with accredited sleep labs or ICUs for ventilator studies.
Home-based trial options for chronic devices (e.g., telemedicine visits for CPAP adherence tracking).

Patient Recruitment

Strict inclusion criteria: Confirm diagnoses via polysomnography (sleep apnea) or spirometry (COPD).
Over-enrollment buffers: Account for high dropout rates in long-term studies (e.g., 6-month CPAP trials).

Clinical Monitoring & Data Management

Real-time respiratory data integration: SpO₂, EtCO₂, and tidal volume metrics synced to EDC systems.
Centralized adjudication: Pulmonologists review adverse events (e.g., auto-PEEP incidents in ventilator trials).

Post-Operative Follow-Up

Extended monitoring: 30–90 days for acute devices (e.g., post-ventilator weaning complications).
PROs & QoL surveys: CAT scores for COPD devices or Epworth Sleepiness Scale for CPAPs.

Respiratory Device Categories We Serve

We conduct trials for:

Mechanical Ventilators (invasive/non-invasive, transport, neonatal).
Sleep Therapy Devices (CPAP, BiPAP, ASV).
Oxygen Delivery Systems (concentrators, portable tanks, high-flow nasal cannulae).
Nebulizers & Inhalers (smart inhalers, vibrating mesh nebulizers).
Diagnostic Tools (spirometers, capnographs, impulse oscillometry).

Why Partner with Meditronics for Respiratory Device Trials?

1. Clinical Expertise: Team includes practicing anesthesiologists.

2. Regulatory Agility: High IDE approval rate for anesthesia devices.

3. Operational Efficiency: 25% faster enrollment timelines.

4. Global Execution: Sites across North America, Europe, and Asia.

Meditronics delivers the most rigorous, compliant clinical trials for anesthesia devices - providing the robust safety and performance data required for global regulatory approvals and clinical adoption.

Online Inquiry

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Need More Information or Request A Quotation?

Send us a request